En randomiseret sammenligning af personlig pleje baseret på hjertesygdomsstadie versus sædvanlig pleje til forebyggelse af hændelser (TRANSFORM)
En randomiseret sammenligning af personlig pleje baseret på stadieinddeling af koronararteriesygdom versus sædvanlig pleje til primær forebyggelse af kardiovaskulære hændelser
TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for atherosclerotic cardiovascular (CV) disease but with no known symptomatic CV disease. The trial tests the hypothesis that a Cleerly Coronary Artery Disease (CAD) Staging System-based care strategy reduces CV events compared with risk factor-based care.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
Cardiovascular disease (CVD) persists as the leading cause of morbidity and mortality worldwide at high societal cost. The current primary CVD prevention strategy relies upon risk stratification using population health markers such as age, sex, diabetes, hypertension, dyslipidemia and tobacco use, with preventive therapy intensified in higher risk strata. Since these risk factors are indirect surrogate markers of the underlying disease, atherosclerosis, this strategy leads to treatment of individuals with risk factors who do not have atherosclerosis and failure to treat those with significant atherosclerosis who lack risk factors. The current strategy also cannot determine which individuals are inadequately treated despite effective risk factor management (residual risk). With the current approach, the CV death rate is trending upward in the US despite evidence that screening asymptomatic patients reduces CV events and the widespread availability of effective preventive therapies.
This randomized, controlled, pragmatic trial is designed to address the unmet need for better strategies to identify asymptomatic individuals at increased risk for CV events due to atherosclerosis and to personalize their treatment based on CV risk estimates using coronary artery disease (CAD) visualization and quantification.
This study enrolls patients without known symptoms of ASCVD but who are at increased risk for ASCVD due to their age and having diabetes, prediabetes or metabolic syndrome and tests the hypothesis that a CAD Staging System-based care strategy reduces CV events compared with risk factor-based care. The Cleerly CAD Staging System incorporates imaging-based evaluation for coronary atherosclerosis, algorithm-supported pharmacotherapy and personalized education about their CAD.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Ryann Sardinia
- Telefonnummer: 7207398191
- E-mail: ryann.sardinia@cleerlyhealth.com
Undersøgelse Kontakt Backup
- Navn: Ashley Dunham, PhD
- Telefonnummer: 7207398191
- E-mail: ashley.dunham@cleerlyhealth.com
Studiesteder
-
-
Arizona
-
Chandler, Arizona, Forenede Stater, 85224
- Rekruttering
- Chandler Clinical Trials
-
Kontakt:
- Muhammad Salim, MD
-
Scottsdale, Arizona, Forenede Stater, 85260
- Rekruttering
- Scottsdale Clinical Trials
-
Kontakt:
- Todd Dreitzler, MD
-
Sun City, Arizona, Forenede Stater, 85381
- Rekruttering
- Sun City Research
-
Kontakt:
- Juan Rodriguez, MD
-
Tucson, Arizona, Forenede Stater, 85704
- Rekruttering
- Noble Clinical Research
-
Kontakt:
- Roxana Rodriguez, MD
-
-
California
-
Beverly Hills, California, Forenede Stater, 90210
- Rekruttering
- Cardiovascular Research Foundation of Southern California
-
Kontakt:
- Ronald P. Karlsberg, MD
-
Beverly Hills, California, Forenede Stater, 90211
- Rekruttering
- Amicis Research: Beverly Hills
-
Kontakt:
- Michael Levine, MD
-
Canoga Park, California, Forenede Stater, 91303
- Rekruttering
- Valiance Clinical Research - Canoga Park
-
Kontakt:
- Rami Shaarawy
-
Chula Vista, California, Forenede Stater, 91911
- Rekruttering
- Cardiovascular Institute of San Diego
-
Kontakt:
- Milind D. Parikh, MD
-
Granada Hills, California, Forenede Stater, 91324
- Rekruttering
- Amicis Research: Granada Hills
-
Kontakt:
- Pascal Dabel, MD
-
Huntington Park, California, Forenede Stater, 90255
- Rekruttering
- Valiance Clinical Research: Huntington Park
-
Kontakt:
- Philip Kim, MD
-
Indian Wells, California, Forenede Stater, 92210
- Rekruttering
- HALO Diagnostics
-
Kontakt:
- John F. Feller, MD
-
La Jolla, California, Forenede Stater, 92037
- Rekruttering
- Scripps Health
-
Kontakt:
- Elizabeth Epstein, MD
-
Lancaster, California, Forenede Stater, 93534
- Rekruttering
- Chemidox Clinical Trials
-
Kontakt:
- Pamela Dewar-DeSilva, MD
-
Loma Linda, California, Forenede Stater, 92354
- Rekruttering
- Loma Linda University Health
-
Kontakt:
- Purvi Parwani, MD
-
Long Beach, California, Forenede Stater, 90805
- Rekruttering
- Long Beach Research Institute
-
Kontakt:
- Ashley Duzik, MD
-
Monterey Park, California, Forenede Stater, 91754
- Rekruttering
- Ace Research Institute - Monterey Park
-
Kontakt:
- Yu-Hsiang Sam Lee, MD
-
Newhall, California, Forenede Stater, 91321
- Rekruttering
- Amicis Research: Newhall
-
Kontakt:
- Thuong Vo, MD
-
Northridge, California, Forenede Stater, 91324
- Rekruttering
- Ace Research Institute: Northridge
-
Kontakt:
- Richard Park, MD
-
Northridge, California, Forenede Stater, 91324
- Rekruttering
- Amicis Research: Northridge
-
Kontakt:
- Nana Barseghian, MD
-
Northridge, California, Forenede Stater, 91325
- Rekruttering
- Ace Research Institute: Northridge #2
-
Kontakt:
- William Y. Josephson, MD
-
Northridge, California, Forenede Stater, 91325
- Aktiv, ikke rekrutterende
- Northridge Clinical Trials
-
Orange, California, Forenede Stater, 92868
- Rekruttering
- University of California- Irvine
-
Kontakt:
- Ailin Barseghian El-Farra, MD
-
Palo Alto, California, Forenede Stater, 94304
- Rekruttering
- Stanford Health Care
-
Kontakt:
- Sandra Tsai, MD
-
Palo Alto, California, Forenede Stater, 94304
- Rekruttering
- VA Palo Alto
-
Kontakt:
- Shriram Nallamshetty, MD
-
San Fernando, California, Forenede Stater, 91306
- Rekruttering
- Amicis Research: San Fernando
-
Kontakt:
- Farid Yasharpour, MD
-
Tarzana, California, Forenede Stater, 91356
- Rekruttering
- Valiance Clinical Research - Tarzana
-
Kontakt:
- Harpreet Singh, MD
-
Torrance, California, Forenede Stater, 90502
- Rekruttering
- Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center
-
Kontakt:
- Suvasini Lakshmanan, MD
-
Valencia, California, Forenede Stater, 91355
- Rekruttering
- Amicis Research: Valencia
-
Kontakt:
- Dennis Lewis, MD
-
Valley Village, California, Forenede Stater, 91607
- Rekruttering
- Concierge Clinical Trials
-
Kontakt:
- Neal R. Cutler, MD
-
-
Colorado
-
Aurora, Colorado, Forenede Stater, 80045
- Rekruttering
- University of Colorado
-
Kontakt:
- Steve Simon
-
Ledende efterforsker:
- Steve Simon, MD
-
Denver, Colorado, Forenede Stater, 80218
- Rekruttering
- St. Josephs (Intermountain Healthcare)
-
Kontakt:
- Christopher Angus, MD
-
-
Florida
-
Boca Raton, Florida, Forenede Stater, 33434
- Rekruttering
- Flourish Medical Research
-
Kontakt:
- Michael Hafran, MD
-
Cross City, Florida, Forenede Stater, 32628
- Rekruttering
- Apex Research
-
Kontakt:
- Tamir Salmani, MD
-
Hialeah, Florida, Forenede Stater, 33012
- Rekruttering
- Evolution Research Center
-
Kontakt:
- Riquel Gonzalez, MD
-
Jacksonville, Florida, Forenede Stater, 32209
- Rekruttering
- UF Health Jacksonville
-
Kontakt:
- Luis Ortega Paz, MD
-
Miami, Florida, Forenede Stater, 33137
- Rekruttering
- BioPhase Research
-
Kontakt:
- Julie Cadet-Plassman, MD
-
Miami, Florida, Forenede Stater, 33135
- Rekruttering
- Fiel Wellness Clinical Research LLC
-
Kontakt:
- Osvaldo Caroma, MD
-
Miami, Florida, Forenede Stater, 33155
- Rekruttering
- United Clinical Research
-
Kontakt:
- Teresa B. Alfonso, MD
-
Kontakt:
- Alfonso
-
Miami, Florida, Forenede Stater, 33173
- Rekruttering
- Atlantis Clinical Research, LLC
-
Kontakt:
- Leyvi Alvarado Miranda, MD
-
Miami, Florida, Forenede Stater, 33183
- Rekruttering
- Farma Medical Inc.
-
Kontakt:
- Ingrid Fernandez-Milian, MD
-
Miami, Florida, Forenede Stater, 33173
- Rekruttering
- Baptist Health Miami Cardiac and Vascular Institute
-
Kontakt:
- Jonathan Fialkow, MD
-
Miami, Florida, Forenede Stater, 33186
- Rekruttering
- New Access Research and Medical Center
-
Kontakt:
- Sander Fernandez, MD
-
Miami Beach, Florida, Forenede Stater, 33140
- Rekruttering
- Quantum Clinical Trials
-
Kontakt:
- Christopher A. Fayeghi, MD
-
Pensacola, Florida, Forenede Stater, 32504
- Rekruttering
- Ascension Sacred Heart
-
Kontakt:
- Rohit Amin, MD
-
Pompano Beach, Florida, Forenede Stater, 33060
- Rekruttering
- Clinical Research Center of Florida
-
Kontakt:
- Howard S. Koch, MD
-
Tampa, Florida, Forenede Stater, 33620
- Rekruttering
- University of South Florida
-
Kontakt:
- Shone Almeida, MD
-
-
Georgia
-
Augusta, Georgia, Forenede Stater, 30907
- Rekruttering
- Aiyan Diabetes Center
-
Kontakt:
- Anthony D. Turner, MD
-
Dunwoody, Georgia, Forenede Stater, 30338
- Rekruttering
- Emory University
-
Kontakt:
- Ambar Kulshreshtha, MD
-
Fayetteville, Georgia, Forenede Stater, 30214
- Rekruttering
- Privia Medical Group Georgia LLC -Fayetteville (Javara)
-
Kontakt:
- Charlotte Grayson Mathis, MD
-
Lithia Springs, Georgia, Forenede Stater, 30122
- Rekruttering
- Randomize Now- Atlanta West
-
Kontakt:
- Millard Collier Jr., MD
-
Macon, Georgia, Forenede Stater, 31210
- Rekruttering
- Randomize Now-Burton Medical
-
Kontakt:
- Frederick Burton, MD
-
Norcross, Georgia, Forenede Stater, 30092
- Rekruttering
- Evergreen Clinical Trials
-
Kontakt:
- Dmitriy Pelishev, MD
-
Powder Springs, Georgia, Forenede Stater, 30127
- Rekruttering
- Peachtree Clinical Solutions - Noir Research Collective
-
Kontakt:
- Karan Raghavan, MD
-
Riverdale, Georgia, Forenede Stater, 30296
- Rekruttering
- Randomize Now, LLC - Noir Research Collective
-
Kontakt:
- Claire K. Willie, MD
-
Savannah, Georgia, Forenede Stater, 31406
- Rekruttering
- Privia Medical Group Georgia, LLC (Javara Inc.)
-
Kontakt:
- Thomas G. Moriarity, MD
-
Thomasville, Georgia, Forenede Stater, 31792
- Rekruttering
- Privia Medical Group Georgia - Thomasville (Javara)
-
Kontakt:
- William L. Cooper, MD
-
-
Idaho
-
Meridian, Idaho, Forenede Stater, 83642
- Rekruttering
- Care Institute- High Desert
-
Kontakt:
- David A. Hinchman, MD
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60611
- Rekruttering
- Northwestern University
-
Kontakt:
- Paul C. Cremer, MD
-
Glenview, Illinois, Forenede Stater, 60026
- Rekruttering
- Northshore University Health System
-
Kontakt:
- Amit K. Pursnani, MD
-
-
Indiana
-
Indianapolis, Indiana, Forenede Stater, 46237
- Rekruttering
- Franciscan Physician Network- Indiana Heart Physicians
-
Kontakt:
- Ryan P Daly, MD
-
Indianapolis, Indiana, Forenede Stater, 46202
- Rekruttering
- Indiana Medical Research Institute
-
Kontakt:
- Arshad P. Malik
-
-
Iowa
-
West Des Moines, Iowa, Forenede Stater, 50266
- Rekruttering
- MercyOne Iowa Heart Center
-
Kontakt:
- Enrico L. Martin, MD
-
-
Kentucky
-
Edgewood, Kentucky, Forenede Stater, 41017
- Rekruttering
- St Elizabeth Health Care - CRI
-
Kontakt:
- Erica Pivato, MD
-
Louisville, Kentucky, Forenede Stater, 40202
- Rekruttering
- UofL Health
-
Kontakt:
- Shahab Ghafghazi, MD
-
-
Louisiana
-
New Orleans, Louisiana, Forenede Stater, 70127
- Rekruttering
- Ascension DePaul Services Research Center
-
Kontakt:
- Kristen Thomas, MD
-
-
Maryland
-
Bowie, Maryland, Forenede Stater, 20715
- Rekruttering
- Flourish Bowie dba Flourish Research
-
Kontakt:
- Sara Collins, MD
-
Columbia, Maryland, Forenede Stater, 21045
- Rekruttering
- KUR Research at CMP
-
Kontakt:
- William Saway, MD
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02115
- Rekruttering
- Brigham and Women's Hospital
-
Kontakt:
- Ron Blankstein, MD
-
Boston, Massachusetts, Forenede Stater, 02114
- Rekruttering
- Massachusetts General Hospital
-
Kontakt:
- Pradeep Natarajan, MD
-
-
Michigan
-
Detroit, Michigan, Forenede Stater, 48202
- Rekruttering
- Henry Ford Hospital
-
Kontakt:
- Cori E Russell, MD
-
Ypsilanti, Michigan, Forenede Stater, 48917
- Rekruttering
- Trinity Health Michigan Heart
-
Kontakt:
- Ahmad Mizyed, MD
-
-
Minnesota
-
Minneapolis, Minnesota, Forenede Stater, 55407
- Rekruttering
- Minneapolis Heart Institute Foundation
-
Kontakt:
- Michael D. Miedema, MD
-
-
Missouri
-
St Louis, Missouri, Forenede Stater, 63110
- Rekruttering
- Washington University School of Medicine
-
Kontakt:
- Farhan M. Katchi, MD
-
St Louis, Missouri, Forenede Stater, 63136
- Rekruttering
- Saint Louis Heart and Vascular
-
Kontakt:
- Gil Vardi, MD
-
-
Montana
-
Kalispell, Montana, Forenede Stater, 59901
- Rekruttering
- Boeson Research Kalispell
-
Kontakt:
- Justin Buls, MD
-
Missoula, Montana, Forenede Stater, 59804
- Rekruttering
- Boeson Research Fort Missoula
-
Kontakt:
- Audrey Remmers, MD
-
-
Nebraska
-
Lincoln, Nebraska, Forenede Stater, 68506
- Rekruttering
- Bryan Heart
-
Kontakt:
- Chad E. Travers, MD
-
-
Nevada
-
Las Vegas, Nevada, Forenede Stater, 89128
- Rekruttering
- Vector Clinical Trials
-
Kontakt:
- Bharat R. Mocherla, MD
-
Las Vegas, Nevada, Forenede Stater, 89102
- Rekruttering
- Southwest Medical Associates- Optum Nevada
-
Kontakt:
- Tatiana O. Tsvetkova, MD
-
-
New Jersey
-
Flemington, New Jersey, Forenede Stater, 08822
- Rekruttering
- Advanced Heart and Vascular Institute of Hunterdon
-
Kontakt:
- Andrey Espinoza, MD
-
Marlton, New Jersey, Forenede Stater, 08053
- Rekruttering
- Virtua Health, Inc.
-
Kontakt:
- Mark T. Finch, MD
-
New Brunswick, New Jersey, Forenede Stater, 08901
- Rekruttering
- Rutgers State University
-
Kontakt:
- Sabahat Bokhari, MD
-
Paramus, New Jersey, Forenede Stater, 07652
- Rekruttering
- The Valley Hospital
-
Kontakt:
- Himanshu Gupta, MD
-
Teaneck, New Jersey, Forenede Stater, 07666
- Rekruttering
- Holy Name Medical Center
-
Kontakt:
- Jaffar Raza, MD
-
-
New York
-
Brooklyn, New York, Forenede Stater, 11221
- Rekruttering
- Clindove Research
-
Kontakt:
- Nelly Cohen, MD
-
Brooklyn, New York, Forenede Stater, 11226
- Rekruttering
- Swift Clinical Research
-
Kontakt:
- Manoj Dalmia, MD
-
Jackson Heights, New York, Forenede Stater, 11372
- Rekruttering
- Rasaj Research
-
Kontakt:
- Ammara Mushtaq, MD
-
Lake Success, New York, Forenede Stater, 11042
- Rekruttering
- Optum- Long Island NY
-
Kontakt:
- Steven Goldberg, MD
-
Mount Kisco, New York, Forenede Stater, 10549
- Rekruttering
- Northwell Health Northern Westchester Hospital
-
Kontakt:
- Margaret Andersen, MD
-
New York, New York, Forenede Stater, 10019
- Rekruttering
- Mount Sinai West
-
Kontakt:
- Waqas A Malick, MD
-
New York, New York, Forenede Stater, 10029
- Rekruttering
- Mount Sinai
-
Kontakt:
- Solomon Bienstock, MD
-
-
North Carolina
-
Chapel Hill, North Carolina, Forenede Stater, 27599
- Rekruttering
- University of North Carolina at Chapel Hill
-
Kontakt:
- Matthew Cavender, MD
-
Durham, North Carolina, Forenede Stater, 27701
- Rekruttering
- Duke University Hospital
-
Kontakt:
- William Yancy, MD
-
Durham, North Carolina, Forenede Stater, 27705
- Rekruttering
- Durham Veterans Affairs Medical Center (Durham VAMC)
-
Kontakt:
- Hayden Bosworth, MD
-
Fayetteville, North Carolina, Forenede Stater, 28304
- Rekruttering
- Cape Fear Valley Health System (Javara Inc.)
-
Kontakt:
- Nafisa Saleem, MD
-
Morehead City, North Carolina, Forenede Stater, 28557
- Aktiv, ikke rekrutterende
- West Clinical Research
-
Winston-Salem, North Carolina, Forenede Stater, 27157
- Rekruttering
- Wake Forest University Health Sciences
-
Kontakt:
- Michael Shapiro, MD
-
-
North Dakota
-
Fargo, North Dakota, Forenede Stater, 58102
- Rekruttering
- Sanford Health
-
Kontakt:
- David J. Clardy, MD
-
-
Ohio
-
Akron, Ohio, Forenede Stater, 44304
- Rekruttering
- Summa Health
-
Kontakt:
- Wissam Alajaji, MD
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forenede Stater, 73109
- Rekruttering
- Medical Research International, LLC
-
Kontakt:
- Joseph Grillo, MD
-
Oklahoma City, Oklahoma, Forenede Stater, 73007
- Rekruttering
- Hightower Clinical
-
Kontakt:
- Faisal Latif, MD
-
Tulsa, Oklahoma, Forenede Stater, 74104
- Rekruttering
- Ascension St. John - Jane Phillips Medical Center
-
Kontakt:
- Michael Megaly, MD
-
-
Pennsylvania
-
Camp Hill, Pennsylvania, Forenede Stater, 17011
- Rekruttering
- Capital Area Research
-
Kontakt:
- Venkatesh Nadar, MD
-
-
South Carolina
-
Charleston, South Carolina, Forenede Stater, 29425
- Rekruttering
- Medical University of South Carolina
-
Kontakt:
- Marc-Andre Cornier, MD
-
-
Tennessee
-
Cleveland, Tennessee, Forenede Stater, 37312
- Rekruttering
- Community DPC
-
Kontakt:
- Carlton Volberg, MD
-
Knoxville, Tennessee, Forenede Stater, 37920
- Rekruttering
- University of Tennessee Medical Center
-
Kontakt:
- Kashif A. Shaikh, MD
-
Nashville, Tennessee, Forenede Stater, 37202
- Rekruttering
- TriStar Centennial Medical Center (HCA Health Care)
-
Kontakt:
- David Huneycutt, MD
-
-
Texas
-
Abilene, Texas, Forenede Stater, 79601
- Rekruttering
- Hendrick Health
-
Kontakt:
- Ren Zhang, MD
-
Beaumont, Texas, Forenede Stater, 77702
- Rekruttering
- Gadolin Research
-
Kontakt:
- John T Fowler, MD
-
Greenville, Texas, Forenede Stater, 75402
- Rekruttering
- CardioVoyage, LLC
-
Kontakt:
- Marc Demyun, MD
-
Houston, Texas, Forenede Stater, 77025
- Rekruttering
- Kelsey Research Foundation
-
Kontakt:
- Rohan R Wagle, MD
-
Houston, Texas, Forenede Stater, 77004
- Rekruttering
- Helium Research Group
-
Kontakt:
- Ijeoma A. Ekeruo
-
Houston, Texas, Forenede Stater, 77070
- Rekruttering
- Gulf Coast Clinical Research, LLC
-
Kontakt:
- Anjani Pandya, MD
-
Houston, Texas, Forenede Stater, 77030
- Rekruttering
- The Methodist Hospital, DeBakey Cardiology Associates
-
Kontakt:
- Sadeer Al-Kindi, MD
-
Laredo, Texas, Forenede Stater, 78041
- Rekruttering
- Aeres Clinical Research
-
Kontakt:
- Amando Garza, MD
-
Lewisville, Texas, Forenede Stater, 75057
- Rekruttering
- DC Clinical Research
-
Kontakt:
- Moiz M. Shafiq, MD
-
McKinney, Texas, Forenede Stater, 75069
- Rekruttering
- North Dallas Research Associates - Kerlo Network
-
Kontakt:
- Muhammad Akram Khan, MD
-
Mesquite, Texas, Forenede Stater, 75149
- Rekruttering
- SMS Clinical Research
-
Kontakt:
- Salma Saiger, MD
-
San Marcos, Texas, Forenede Stater, 78666
- Rekruttering
- Privia Medical Group Gulf Coast, PLLC ( Javara Inc.)
-
Kontakt:
- Alan Lee, MD
-
Stephenville, Texas, Forenede Stater, 76401
- Rekruttering
- Privia Medical Group- North Texas
-
Kontakt:
- Benjamin Marcum, MD
-
-
Utah
-
West Valley City, Utah, Forenede Stater, 84120
- Ikke rekrutterer endnu
- Kalo Clinical Research
-
Kontakt:
- William J. Walsh, MD
-
-
Virginia
-
Richmond, Virginia, Forenede Stater, 23225
- Rekruttering
- Chippenham Johnston Willis Medical Center
-
Kontakt:
- Michael Arcarese, MD
-
-
Washington
-
Everett, Washington, Forenede Stater, 98201
- Rekruttering
- Providence Regional Medical Center Everett
-
Kontakt:
- Xiaojing Jennie Shen, MD
-
Seattle, Washington, Forenede Stater, 98195
- Rekruttering
- University of Washington
-
Kontakt:
- Kelley Branch, MD
-
-
West Virginia
-
Charleston, West Virginia, Forenede Stater, 25304
- Rekruttering
- Charleston Area Medical Center
-
Kontakt:
- Sarah Rinehart, MD
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
-
Provided electronic or written informed consent
-
Men > 55, women > 65 years of age
-
Type 2 diabetes mellitus requiring pharmacologic therapy or with their most recent A1c 6.5%. Patients with prediabetes (most recent HbA1c 5.7 to 6.4% and/or fasting glucose 100-125 mg/dL [5.6-6.9 mmol/L]) and/or metabolic syndrome can be enrolled through 12 October 2026 and proceed with randomization; however, no additional participants may enroll with these criteria after this date. Metabolic syndrome is defined as > 3 of the following criteria (International Diabetes Federation 2006):
- Body mass index ≥ 27 kg/m2 or abnormal waist circumference defined as ≥ 80 cm (31.5 inches) for women, ≥ 94 cm (37 inches) for men; for South and East Asian men (e.g., Asian Indian, Chinese, Japanese) ≥ 90 cm (35.4 inches)
- Fasting triglycerides ≥ 150 mg/dL (1.7 mmol/L) or treated hypertriglyceridemia
- HDL-cholesterol (HDL-C) < 40 mg/dL (1.03 mmol/L) in men, <50 mg/dL (1.29 mmol/L) in women or treatment for this lipid abnormality
- Systolic blood pressure (BP) ≥ 130 and/or diastolic BP≥ 85 mm Hg and/or treated hypertension
- Fasting blood glucose ≥ 100 mg/dL (5.6 mmol/L) or HbA1c ≥ 5.7%
-
Have a device (e.g., smartphone, tablet, computer) for communication with the central cardiologist-led team managing drug treatment for the personalized care group
Exclusion Criteria:
-
Any one of the following:
- A history of acute myocardial infarction (heart attack), stroke, or non-traumatic leg/foot/toe amputation
- A history of an arterial revascularization procedure for coronary, peripheral, and/or carotid atherosclerotic disease (i.e. coronary stent or bypass, carotid stent)
- Symptoms suspicious of coronary artery disease, stroke or peripheral artery disease confirmed by a diagnostic test within the last 12 months (i.e. nuclear stress test, invasive angiogram, brain MRI/CT
- Asymptomatic ASCVD including treatment with therapies (e.g. antiplatelets, lipid lowering) intended to reduce CV risk due to the imaging evidence of atherosclerosis and/or management to goals consistent with secondary prevention guidelines (e.g. LDL-C < 70 mg/dL)
-
Planned arterial revascularization
-
Inability to complete screening CCTA or any condition that would increase the risk associated with CCTA or increase likelihood of uninterpretable scan including:
- eGFR < 60 mL/min/1.73 m2 by the Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) or Modification of Diet in Renal Disease (MDRD) equation (www.kidney.org/professionals/kdoqi/gfr_calculator)
- Allergy to iodinated contrast or history of contrast-induced nephropathy (including adverse reaction to contrast at screening CCTA) or screening laboratory values consistent with untreated hyperthyroidism. Participants with elevated thyroid-stimulating hormone (TSH) may be enrolled but should be referred to their physician for evaluation for treatment.
- Thyroid cancer in the previous five (5) years or planned radioactive iodine treatment
- Weight > 300 lbs. (136 kg) or above manufacturer-recommended limit for scanner and table at the site
- Inability to hold breath for > 10 seconds
- Active arrhythmia (atrial fibrillation, atrial flutter, frequent premature atrial, or ventricular contractions) with poorly controlled rate (i.e., > 80 beats per minute at screening or prior to CCTA)
- Contraindication to dosing with beta blocker or nitroglycerin on day of screening CCTA
- Any other factor that, in the opinion of the investigator, would increase participant risk or increase the chance of an uninterpretable CCTA
-
Unsuitable as a trial participant in the opinion of the investigator for reasons including significant left main stenosis (e.g. ≥ 70%; site will be notified by Cleerly), other health condition with life expectancy < 3 years or being at risk of poor compliance with study procedures (e.g., active substance abuse or untreated mental illness that, in the opinion of the investigator, is likely to adversely affect adherence or retention)
-
Unwilling or unable to receive specialty care per the trial protocol
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Ingen indgriben: Risk Factor-Based Care
The risk factor-based care group will be managed by their usual care providers, with an initial pre-randomization assessment of current treatment by a centralized cardiology team to optimize care relative to primary prevention guidelines. During the trial, the centralized cardiology team will monitor the provision of medications prescribed and lab values relative to guidelines, and provide feedback and education to site investigators to support optimization. CCTA results will be centrally archived and will remain blinded to the usual care provider until the end of the study. |
|
|
Eksperimentel: Cleerly Stage-Based Care
The Cleerly Stage-Based Care group will receive personalized care centrally managed by a remote cardiologist-led team. They will also receive an initial pre-randomization assessment of current treatment by a centralized cardiology team to optimize care relative to primary prevention guidelines. Cleerly CAD Staging System results will be discussed with participants and serve as the basis for standardized algorithm-supported pharmacotherapy & education, which will be intensified if plaque burden has progressed at 24 months. |
The Cleerly CAD Staging System is software that utilizes a proprietary algorithm to identify CAD, stage the severity of CAD when present, and generate a prognostic risk score to inform treatment decisions that support CV disease prevention. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
The primary objective is to compare Cleerly stage-based care with risk factor-based care on the risk of CV events.
Tidsramme: Through study completion- an average of 3.5 years
|
The primary endpoint is total (first and subsequent) events for the composite endpoint of CV death, myocardial infarction (MI), ischemic stroke, acute limb ischemia, clinically driven arterial revascularization, and hospitalization or urgent visit for heart failure. |
Through study completion- an average of 3.5 years
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Tidsramme: Through study completion- an average of 3.5 years
|
The secondary endpoints are time from randomization to first occurence of an event in the primary efficacy endpoint. |
Through study completion- an average of 3.5 years
|
|
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Tidsramme: Through study completion- an average of 3.5 years
|
The secondary endpoints are total occurences after randomization of the primary efficacy endpoing, kidney failure, sustained estimated glomerular filtration rate (eGFR) decrease >40% from baseline, and death from renal causes. |
Through study completion- an average of 3.5 years
|
|
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Tidsramme: Through study completion- an average of 3.5 years
|
The secondary endpoints are first and total occurrences after randomization of coronary death, MI, and urgent coronary revascularization. |
Through study completion- an average of 3.5 years
|
|
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Tidsramme: Through study completion- an average of 3.5 years
|
The secondary endpoints are time from randomization to first occurrence of MI or ischemic stroke. |
Through study completion- an average of 3.5 years
|
|
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
Tidsramme: Through study completion- an average of 3.5 years
|
The secondary endpoints are time from randomization to all-cause death. |
Through study completion- an average of 3.5 years
|
Andre resultatmål
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
The safety objective is to assess harm with the 2 prevention strategies
Tidsramme: Through study completion- an average of 3.5 years
|
The safety endpoints are Adverse events (AE) leading to discontinuation of study-recommended medication (DAE), serious AE (SAE), adverse device effect (ADE). |
Through study completion- an average of 3.5 years
|
|
The safety objective is to assess harm with the 2 prevention strategies
Tidsramme: Through study completion- an average of 3.5 years
|
The safety endpoints are 20-item Short Form survey (SF-20). |
Through study completion- an average of 3.5 years
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Efterforskere
Efterforskere
- Studiestol: Deepak Bhatt, MD, MPH, Mt. Sinai Heart
- Studiestol: David J. Maron, MD, FASPC, Stanford University
Publikationer og nyttige links
Generelle publikationer
- Clerc OF, Fuchs TA, Stehli J, Benz DC, Grani C, Messerli M, Giannopoulos AA, Buechel RR, Luscher TF, Pazhenkottil AP, Kaufmann PA, Gaemperli O. Non-invasive screening for coronary artery disease in asymptomatic diabetic patients: a systematic review and meta-analysis of randomised controlled trials. Eur Heart J Cardiovasc Imaging. 2018 Aug 1;19(8):838-846. doi: 10.1093/ehjci/jey014.
- Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, Elkind MSV, Evenson KR, Eze-Nliam C, Ferguson JF, Generoso G, Ho JE, Kalani R, Khan SS, Kissela BM, Knutson KL, Levine DA, Lewis TT, Liu J, Loop MS, Ma J, Mussolino ME, Navaneethan SD, Perak AM, Poudel R, Rezk-Hanna M, Roth GA, Schroeder EB, Shah SH, Thacker EL, VanWagner LB, Virani SS, Voecks JH, Wang NY, Yaffe K, Martin SS. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- 202302CPC
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .